NO20051901L - Nye antimycobakterielle sammensetninger og pyrrole derivater som antimycobakterielle sammensetninger - Google Patents
Nye antimycobakterielle sammensetninger og pyrrole derivater som antimycobakterielle sammensetningerInfo
- Publication number
- NO20051901L NO20051901L NO20051901A NO20051901A NO20051901L NO 20051901 L NO20051901 L NO 20051901L NO 20051901 A NO20051901 A NO 20051901A NO 20051901 A NO20051901 A NO 20051901A NO 20051901 L NO20051901 L NO 20051901L
- Authority
- NO
- Norway
- Prior art keywords
- antimycobacterial
- compositions
- compounds
- new
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Abstract
Nye pyrrol derivater med formel (I). og deres farmasøytisk akseptable syre addisjons salter som har overlegen antimycobakterielle aktivitet mot klinisk sensitive så vel som resistente stammer av Mycobacterium tuberculosis samt at de har lavere toksisitet sammenliknet med kjente forbindelser. Anvendelse av de nye forbindelsene med formel (I) for behandling av latent tuberkulose inkludert Multi Drug Resistent Tuberkulose (MDR TB). Det blir beskrevet fremgangsmåter for fremstilling av de nye forbindelsene, farmasøytiske sammensetninger som inneholder de nye forbindelsene og fremgangsmåter for behandling av MDR TB ved administrering av forbindelsene med formel (I).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2002/000189 WO2004026828A1 (en) | 2002-09-20 | 2002-09-20 | Pyrrole derivatives as antimycobacterial compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20051901L true NO20051901L (no) | 2005-04-19 |
Family
ID=32012142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20051901A NO20051901L (no) | 2002-09-20 | 2005-04-19 | Nye antimycobakterielle sammensetninger og pyrrole derivater som antimycobakterielle sammensetninger |
Country Status (19)
Country | Link |
---|---|
US (2) | US7691837B2 (no) |
EP (2) | EP1857442A3 (no) |
JP (1) | JP2006503837A (no) |
CN (1) | CN1668584A (no) |
AP (1) | AP1979A (no) |
AU (1) | AU2002343200B2 (no) |
BR (1) | BR0215873A (no) |
CA (1) | CA2499701A1 (no) |
EA (1) | EA012461B1 (no) |
HR (1) | HRP20050347A2 (no) |
HU (1) | HUP0500598A2 (no) |
IS (1) | IS7795A (no) |
MX (1) | MXPA05003022A (no) |
NO (1) | NO20051901L (no) |
NZ (1) | NZ539449A (no) |
RS (1) | RS20050231A (no) |
TN (1) | TNSN05080A1 (no) |
UA (1) | UA81640C2 (no) |
WO (1) | WO2004026828A1 (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7491721B2 (en) * | 2004-05-12 | 2009-02-17 | Lupin Limited | Antimycobacterial pharmaceutical composition |
CN101163693B (zh) * | 2005-02-18 | 2013-03-06 | 阿斯利康(瑞典)有限公司 | 抗菌哌啶衍生物 |
ITRM20050094A1 (it) | 2005-03-04 | 2006-09-05 | Univ Siena | Derivati del 1-(1,5-di(4-clorofenil)-2metil-1h-3-pirroli)metil)-4-metilpiperazina (bm 212), procedimento per la loro produzione e uso di essi come antitubercolari. |
US20090118509A1 (en) * | 2005-04-11 | 2009-05-07 | Lupin Limited | Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives |
CN101190894A (zh) * | 2006-11-23 | 2008-06-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 脂肪酸合成酶抑制剂及其制药用途 |
EP2311457A1 (en) | 2009-10-19 | 2011-04-20 | Forschungszentrum Borstel | Pharmaceutical compositions for treating infections with drug resistant mycobacteria |
HUP1000033A2 (en) * | 2010-01-21 | 2011-07-28 | Uratim Kft | Piperazine derivatives useful against mycobacteriums |
CN102802650B (zh) * | 2010-03-22 | 2014-05-21 | 科学与工业技术研究委员会 | 刺果藤属物种的抗结核病组合物 |
KR100998556B1 (ko) | 2010-04-08 | 2010-12-07 | 강원대학교산학협력단 | 신규한 다치환 피롤 유도체와 이의 제조방법 |
CN103122370B (zh) * | 2011-11-21 | 2014-06-18 | 华中农业大学 | 一种三嗪类化合物作为抗结核分枝杆菌抑制剂的应用 |
CN104428261B (zh) | 2012-07-13 | 2018-09-11 | 康宁股份有限公司 | 制备层压玻璃片的方法和设备 |
WO2014195970A1 (en) | 2013-06-03 | 2014-12-11 | Council Of Scientific & Industrial Research | Novel pyrrole compounds with silicon incorporation |
RU2767542C1 (ru) * | 2021-05-24 | 2022-03-17 | Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" (ПГНИУ) | Противотуберкулезное средство на основе 4-((гет)ароил)-3- гидрокси-1-(2-гидроксифенил)-5-(фенилтио)-1,5-дигидро-2Н-пиррол-2-онов |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2986564A (en) | 1959-02-20 | 1961-05-30 | Rips Richard | Pyrrole compounds |
US3246010A (en) * | 1963-06-10 | 1966-04-12 | Parke Davis & Co | 1, 5-diaryl-2-pyrrole propanols and ethers |
US3168532A (en) * | 1963-06-12 | 1965-02-02 | Parke Davis & Co | 1, 5-diarylpyrrole-2-propionic acid compounds |
US3168531A (en) * | 1963-06-12 | 1965-02-02 | Parke Davis & Co | 1-aryl-5-(p-lower alkoxyphenyl)-pyrrole-2-propionic acid compounds |
DE1938904A1 (de) * | 1968-08-02 | 1970-02-05 | Innothera Lab Sa | 1-Phenylpyrrole |
-
2002
- 2002-09-20 JP JP2004537473A patent/JP2006503837A/ja active Pending
- 2002-09-20 EP EP07017067A patent/EP1857442A3/en not_active Withdrawn
- 2002-09-20 NZ NZ539449A patent/NZ539449A/en not_active IP Right Cessation
- 2002-09-20 AP AP2005003277A patent/AP1979A/xx active
- 2002-09-20 AU AU2002343200A patent/AU2002343200B2/en not_active Ceased
- 2002-09-20 CA CA002499701A patent/CA2499701A1/en not_active Abandoned
- 2002-09-20 CN CNA028296346A patent/CN1668584A/zh active Pending
- 2002-09-20 UA UAA200503537A patent/UA81640C2/ru unknown
- 2002-09-20 RS YUP-2005/0231A patent/RS20050231A/sr unknown
- 2002-09-20 US US10/497,615 patent/US7691837B2/en not_active Expired - Fee Related
- 2002-09-20 MX MXPA05003022A patent/MXPA05003022A/es unknown
- 2002-09-20 EA EA200500500A patent/EA012461B1/ru not_active IP Right Cessation
- 2002-09-20 HU HU0500598A patent/HUP0500598A2/hu unknown
- 2002-09-20 EP EP02779869A patent/EP1546097A1/en not_active Withdrawn
- 2002-09-20 WO PCT/IN2002/000189 patent/WO2004026828A1/en not_active Application Discontinuation
- 2002-09-20 BR BR0215873-6A patent/BR0215873A/pt not_active IP Right Cessation
-
2005
- 2005-03-18 TN TNP2005000080A patent/TNSN05080A1/en unknown
- 2005-04-11 IS IS7795A patent/IS7795A/is unknown
- 2005-04-19 NO NO20051901A patent/NO20051901L/no not_active Application Discontinuation
- 2005-04-19 HR HR20050347A patent/HRP20050347A2/hr not_active Application Discontinuation
-
2008
- 2008-06-11 US US12/137,170 patent/US7763602B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2499701A1 (en) | 2004-04-01 |
EP1857442A3 (en) | 2008-02-06 |
JP2006503837A (ja) | 2006-02-02 |
IS7795A (is) | 2005-04-11 |
EA200500500A1 (ru) | 2006-02-24 |
AP2005003277A0 (en) | 2005-06-30 |
RS20050231A (en) | 2007-06-04 |
BR0215873A (pt) | 2005-07-12 |
EP1546097A1 (en) | 2005-06-29 |
AU2002343200A1 (en) | 2004-04-08 |
US20050107370A1 (en) | 2005-05-19 |
WO2004026828A1 (en) | 2004-04-01 |
AP1979A (en) | 2009-03-20 |
CN1668584A (zh) | 2005-09-14 |
AU2002343200B2 (en) | 2009-08-13 |
UA81640C2 (ru) | 2008-01-25 |
NZ539449A (en) | 2007-08-31 |
US7763602B2 (en) | 2010-07-27 |
MXPA05003022A (es) | 2005-05-27 |
TNSN05080A1 (en) | 2007-05-14 |
EP1857442A2 (en) | 2007-11-21 |
US20080242676A1 (en) | 2008-10-02 |
EA012461B1 (ru) | 2009-10-30 |
HUP0500598A2 (en) | 2006-02-28 |
HRP20050347A2 (en) | 2006-03-31 |
US7691837B2 (en) | 2010-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20051901L (no) | Nye antimycobakterielle sammensetninger og pyrrole derivater som antimycobakterielle sammensetninger | |
WO2003011880A1 (fr) | Derive de glucopyranosyloxybenzylbenzene, composition medicinale contenant ce derive, usage medicinal de cette composition et produit intermediaire pour produire cette composition | |
NO20071140L (no) | Nye piperidinderivater som histamin H3 reseptorligander for behandling av depresjon | |
NO20063475L (no) | Nye 2-heteroarylsubstituerte benzimidazolderivater | |
NO20074012L (no) | 1-tio-D-glucitolderivater | |
NO20081970L (no) | Sulfonamidderivat med PGD2-reseptorantagonistaktivitet | |
DK1213296T3 (da) | Glucopyranosyloxpyrazolderivater, lægemidler indeholdende samme samt mellemprodukter til fremstilling heraf | |
NO20061657L (no) | Pyrolderivater med antibakteriell aktivitet | |
NO20054220L (no) | Substituerte N-arylheterocykler, fremgangsmate for fremstilling derav og deres anvendelse som legemiddel | |
NO20045103L (no) | Benzofuserte heteroarylamid-derivater av thienopyridiner anvendelige som terapeutiske midler, farmasoytiske blandinger omfattende de samme og fremgangsmater for deres anvendelse | |
NO20082445L (no) | Neuropeptid-2 reseptor-agonister | |
NO20074620L (no) | Spiroheterocykliske forbindelser og deres anvendelse som medikamenter | |
NO20045486L (no) | Nye forbindelser og deres anvendelse | |
NO20052683L (no) | Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
NO20065060L (no) | Farmasoytiske kombinasjoner inneholdende benzoksazin for behandling av respiratoriske forstyrrelser | |
CY1105631T1 (el) | Υποκατεστημενα παραγωγα καρβοστυριλης ως αγωνιστες 5-ητ1α υποτυπου δεκτη | |
NO20053410L (no) | 4-aminopyrimidin-5-on. | |
NO20053483L (no) | 4-Anilinokinazolinderivater for behandling av unormal cellevekst | |
CA2336412A1 (en) | Medicament for treatment of diabetes | |
EA200500096A1 (ru) | Гетеробиарильные производные в качестве ингибиторов матриксных металлопротеиназ | |
US20150291568A1 (en) | New compounds having a protective activity against toxins with intracellular activity | |
WO2000068198A3 (en) | Heterosubstituted pyridine derivatives as pde 4 inhibitors | |
HUP0300370A2 (hu) | Antimikrobiális hatású 2-hidroxi-mutilin-karbamát-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
EA200800071A1 (ru) | Производные бензофуранила как ингибиторы 5-нт6-рецептора | |
NO20083790L (no) | Nye terapeutiske kombinasjoner for behandling eller forebygging av psykotiske lidelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |